Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Sotagliflozin with Metoprolol and Midazolam in Healthy Subjects
NCT02940379Phase 1Completed
- Sponsor
- Sanofi
- Start
- Oct 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of sotagliflozin in type 2 diabetes mellitus (T2DM) (2 cohorts), sponsored by Sanofi. Primary endpoints: Area under the plasma concentration versus time curve for midazolam and Area under the plasma concentration versus time curve for metoprolol. Started Oct 2016; status: completed.
02
Drugs
sotagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02940379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02940379.